Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2004 1
2007 1
2011 2
2012 4
2013 1
2017 1
2019 2
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Increased risk for hematologic cancer, particularly acute myeloid leukemia"
Page 1
Therapy-related myeloid neoplasms in lymphoma survivors: Reducing risks.
Al-Juhaishi T, Khurana A, Shafer D. Al-Juhaishi T, et al. Best Pract Res Clin Haematol. 2019 Mar;32(1):47-53. doi: 10.1016/j.beha.2019.02.008. Epub 2019 Feb 16. Best Pract Res Clin Haematol. 2019. PMID: 30927975 Review.
Treatment for Hodgkin (HL) and non-Hodgkin's lymphoma (NHL) has changed dramatically in the last fifty years. While there are increasing numbers of long-term survivors, there has been increasing recognition of the long-term toxicities of treatments, particularly …
Treatment for Hodgkin (HL) and non-Hodgkin's lymphoma (NHL) has changed dramatically in the last fifty years. While there are increasing …
Acute myeloid leukemia developing in patients with autoimmune diseases.
Ramadan SM, Fouad TM, Summa V, Hasan SKh, Lo-Coco F. Ramadan SM, et al. Haematologica. 2012 Jun;97(6):805-17. doi: 10.3324/haematol.2011.056283. Epub 2011 Dec 16. Haematologica. 2012. PMID: 22180424 Free PMC article. Review.
Therapy-related acute myeloid leukemia is an unfortunate complication of cancer treatment, particularly for patients with highly curable primary malignancies and favorable life expectancy. ...Given the dismal outcome of secondary acute …
Therapy-related acute myeloid leukemia is an unfortunate complication of cancer treatment, particularly f …
Current Concepts of Pathogenesis and Treatment of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Zeeh FC, Meyer SC. Zeeh FC, et al. Hamostaseologie. 2021 Jun;41(3):197-205. doi: 10.1055/a-1447-6667. Epub 2021 Jun 30. Hamostaseologie. 2021. PMID: 34192778 Free article. Review.
Philadelphia chromosome-negative myeloproliferative neoplasms are hematopoietic stem cell disorders characterized by dysregulated proliferation of mature myeloid blood cells. ...They share a propensity for thrombo-hemorrhagic complications and the risk of pro …
Philadelphia chromosome-negative myeloproliferative neoplasms are hematopoietic stem cell disorders characterized by dysregulated pro …
Revisiting use of growth factors in myelodysplastic syndromes.
Newman K, Maness-Harris L, El-Hemaidi I, Akhtari M. Newman K, et al. Asian Pac J Cancer Prev. 2012;13(4):1081-91. doi: 10.7314/apjcp.2012.13.4.1081. Asian Pac J Cancer Prev. 2012. PMID: 22799286 Free article. Review.
Myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal hematologic neoplasms characterized by morphologic dysplasia, aberrant hematopoiesis and peripheral blood refractory cytopenias. MDS is recognized to be associated with an increased …
Myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal hematologic neoplasms characterized by morphologic d …
Benzene and lymphohematopoietic malignancies in humans.
Hayes RB, Songnian Y, Dosemeci M, Linet M. Hayes RB, et al. Am J Ind Med. 2001 Aug;40(2):117-26. doi: 10.1002/ajim.1078. Am J Ind Med. 2001. PMID: 11494338 Review.
METHODS: We review the evidence implicating benzene in the etiology of hematopoietic disorders, clarify methodologic aspects of the NCI/CAPM study, and examine the study in the context of the broader literature on health effects associated with occupational benzene exposure. RESU …
METHODS: We review the evidence implicating benzene in the etiology of hematopoietic disorders, clarify methodologic aspects of the NCI/CAPM …
Therapy-related leukemia and myelodysplasia: susceptibility and incidence.
Leone G, Pagano L, Ben-Yehuda D, Voso MT. Leone G, et al. Haematologica. 2007 Oct;92(10):1389-98. doi: 10.3324/haematol.11034. Haematologica. 2007. PMID: 17768113 Free article.
Therapy-related myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) is an increasingly recognized treatment complication in patients treated with radiotherapy or chemotherapy for previous hematologic malignancies or solid tumors. ...The additio …
Therapy-related myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) is an increasingly recognized treatment com …
Acute myeloid leukemia following exposure to benzene more closely resembles de novo than therapy related-disease.
Irons RD, Chen Y, Wang X, Ryder J, Kerzic PJ. Irons RD, et al. Genes Chromosomes Cancer. 2013 Oct;52(10):887-94. doi: 10.1002/gcc.22084. Epub 2013 Jul 10. Genes Chromosomes Cancer. 2013. PMID: 23840003
Benzene (Bz) is widely regarded as a prototype environmental leukemogen and individuals chronically exposed are at risk for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). ...These findings are important for further understanding the b …
Benzene (Bz) is widely regarded as a prototype environmental leukemogen and individuals chronically exposed are at risk for myelodysp …
Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS.
Leone G, Voso MT, Teofili L, Lübbert M. Leone G, et al. Clin Immunol. 2003 Oct;109(1):89-102. doi: 10.1016/s1521-6616(03)00207-9. Clin Immunol. 2003. PMID: 14585280 Review.
DNA methylation abnormalities have recently emerged as one of the most frequent molecular changes in hematopoietic neoplasms. Since methylation and transcriptional status are inversely correlated, the hypermethylation of genes involved in cell-cycle control and apoptosis c …
DNA methylation abnormalities have recently emerged as one of the most frequent molecular changes in hematopoietic neoplasms. Since m …
Treatment decisions for elderly patients with haematological malignancies: a dilemma.
Peyrade F, Gastaud L, Ré D, Pacquelet-Cheli S, Thyss A. Peyrade F, et al. Lancet Oncol. 2012 Aug;13(8):e344-52. doi: 10.1016/S1470-2045(12)70234-6. Lancet Oncol. 2012. PMID: 22846839 Review.
Over the past decade, haematological malignant diseases have been diagnosed with increasing frequency in patients older than 65 years. The management of these diseases is particularly difficult in elderly patients, as non-tumour-related life expectancy is highly var …
Over the past decade, haematological malignant diseases have been diagnosed with increasing frequency in patients older than 65 years …
Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia.
Braun TP, Coblentz C, Curtiss BM, Coleman DJ, Schonrock Z, Carratt SA, Callahan RL, Maniaci B, Druker BJ, Maxson JE. Braun TP, et al. Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13670-13679. doi: 10.1073/pnas.1918307117. Epub 2020 May 29. Proc Natl Acad Sci U S A. 2020. PMID: 32471953 Free PMC article.
Acute myeloid leukemia (AML) is a deadly hematologic malignancy with poor prognosis, particularly in the elderly. ...Mutations in the transcription factor CEBPA are associated with favorable risk in AML. However, mutations in the growth f …
Acute myeloid leukemia (AML) is a deadly hematologic malignancy with poor prognosis, particularly in the …
15 results